References: Nagaya,N.; Kojima,M.; Kangawa,K.. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern.Med 2006;45:127-134. (Link)
Kao,P.C.; Shiesh,S.C.; Wu,T.J.. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci. 2006;36:163-169. (Link)
Despres,J.P.. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 2006;29:77-82. (Link)
Friedman,A.N.. Adiposity in dialysis: good or bad?. Semin.Dial. 2006;19:136-140. (Link)
Bray,G.A.; Bellanger,T.. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 2006;29:109-117. (Link)
McGavock,J.M.; Victor,R.G.; Unger,R.H.; Szczepaniak,L.S.. Adiposity of the heart, revisited. Ann Intern.Med 2006;144:517-524. (Link)
Das,S.K.. Body composition measurement in severe obesity. Curr.Opin.Clin Nutr Metab Care 2005;8:602-606. (Link)
Ahima,R.S.. Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity (Silver.Spring) 2006;14 Suppl 1:9S-15S. (Link)
Hauguel-de,Mouzon S.; Lepercq,J.; Catalano,P.. The known and unknown of leptin in pregnancy. Am J Obstet.Gynecol. 2006;194:1537-1545. (Link)